1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.2.1 INCLUSIONS & EXCLUSIONS 21
1.3 MARKET SCOPE 22
1.3.1 MARKETS COVERED 22
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 23
1.5 LIMITATIONS 23
1.6 STAKEHOLDERS 23
1.7 SUMMARY OF CHANGES 24

2 RESEARCH METHODOLOGY 25
2.1 RESEARCH DATA 25
2.1.1 SECONDARY DATA 25
2.1.2 PRIMARY DATA 26
2.1.3 MARKET DATA ESTIMATION AND TRIANGULATION 27
2.1.4 DATA TRIANGULATION 27
FIGURE 1 DATA TRIANGULATION METHODOLOGY 27
2.2 MARKET ESTIMATION METHODOLOGY 28
FIGURE 2 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION) 28
FIGURE 3 GENOMICS MARKET SIZE (USD BILLION) 29
FIGURE 4 GENOMICS MARKET: FINAL CAGR PROJECTIONS (2020?2025) 29
FIGURE 5 GENOMICS MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS, OPPORTUNITIES, AND CHALLENGES 30
FIGURE 6 GENOMICS MARKET: SEGMENTAL ASSESSMENT 31
2.3 INDUSTRY INSIGHTS 31
2.4 RESEARCH ASSUMPTIONS 32

3 EXECUTIVE SUMMARY 33
FIGURE 7 GENOMICS MARKET, BY PRODUCT & SERVICE,

2020 VS. 2025 (USD BILLION) 33
FIGURE 8 GENOMICS MARKET SHARE, BY TECHNOLOGY, 2019 34
FIGURE 9 GENOMICS MARKET, BY APPLICATION, 2020 VS. 2025 (USD BILLION) 34
FIGURE 10 GENOMICS MARKET, BY END USER, 2020?2025 35
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE GENOMICS MARKET 36

4 PREMIUM INSIGHTS 37
4.1 GENOMICS MARKET OVERVIEW 37
FIGURE 12 INCREASING GOVERNMENT FUNDING TO SUPPORT GENOMICS PROJECTS TO DRIVE MARKET GROWTH 37
4.2 ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION & COUNTRY (2019) 38
FIGURE 13 DRUG DISCOVERY AND DEVELOPMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2019 38
4.3 GENOMICS MARKET FOR SEQUENCING, BY TYPE 39
FIGURE 14 NEXT-GENERATION SEQUENCING PROJECTED TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 39

5 MARKET OVERVIEW 40
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
FIGURE 15 GENOMICS MARKET: DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS 40
5.2.1 DRIVERS 41
5.2.1.1 Increasing government funding to support genomics projects 41
5.2.1.2 Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research 41
TABLE 1 GLOBAL CANCER INCIDENCE, 2020 VS. 2040 41
5.2.1.3 Entry of new players and start-ups in the genomics market 42
5.2.1.4 Growing application areas of genomics 42
5.2.2 OPPORTUNITIES 43
5.2.2.1 Use of genomics in specialized/personalized medicine 43
5.2.3 CHALLENGES 43
5.2.3.1 High cost of genomic equipment 43
5.2.3.2 Dearth of trained professionals 44
5.2.3.3 Secure storage of large volumes of sequenced data 44
5.2.4 TRENDS 45
5.2.4.1 Partnerships and collaborations for technological advancements in genomics 45
5.2.4.2 Impact of COVID-19 on the genomics market 46
5.3 TECHNOLOGICAL ANALYSIS 48
TABLE 2 COMPARISON OF SANGER SEQUENCING AND NGS 48
5.4 VALUE CHAIN ANALYSIS 50
FIGURE 16 VALUE CHAIN ANALYSIS—MAXIMUM VALUE IS ADDED DURING THE SEQUENCING AND ANALYSIS PHASE 50
5.5 REGULATORY ANALYSIS 51
5.5.1 NORTH AMERICA 51
5.5.1.1 US 51
TABLE 3 US FDA: MEDICAL DEVICE CLASSIFICATION 52
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 52
5.5.2 EUROPE 53
FIGURE 17 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR) 54
5.5.2.1 Asia Pacific 55
5.5.2.1.1 China 55
TABLE 5 CHINA: CLASSIFICATION OF MEDICAL DEVICES 55
5.6 ECOSYSTEM ANALYSIS OF THE GENOMICS MARKET 56
FIGURE 18 ECOSYSTEM ANALYSIS OF THE GENOMICS MARKET 56

6 GENOMICS MARKET, BY PRODUCT & SERVICE 57
6.1 INTRODUCTION 58
TABLE 6 GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 58
6.2 CONSUMABLES 58
6.2.1 CONSUMABLES FORM THE LARGEST PRODUCT SEGMENT OF THE GENOMICS MARKET 58
TABLE 7 GENOMICS CONSUMABLES MARKET, BY REGION,
2018-2025 (USD MILLION) 59
TABLE 8 GENOMICS CONSUMABLES MARKET, BY COUNTRY,
2018-2025 (USD MILLION) 60
6.3 SYSTEMS & SOFTWARE 60
6.3.1 DECLINING RATES OF GENOME SEQUENCING TO INCREASE THE DEMAND FOR GENOMICS SYSTEMS & SOFTWARE 60
TABLE 9 GENOMICS SYSTEMS & SOFTWARE MARKET, BY REGION,
2018-2025 (USD MILLION) 62
TABLE 10 GENOMICS SYSTEMS & SOFTWARE MARKET, BY COUNTRY,
2018-2025 (USD MILLION) 63
6.4 SERVICES 63
6.4.1 HIGH COST OF GENOMIC INSTRUMENTS AND THE POSSIBILITY OF INSTRUMENT OBSOLESCENCE HAVE DRIVEN END USERS TO OUTSOURCE THEIR SEQUENCING NEEDS 63
TABLE 11 GENOMICS SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION) 64
TABLE 12 GENOMICS SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 64

7 GENOMICS MARKET, BY TECHNOLOGY 65
7.1 INTRODUCTION 66
TABLE 13 GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION) 66
7.2 SEQUENCING 66
7.2.1 INCREASING APPLICATIONS OF SEQUENCING IN HUMAN GENOMICS TO DRIVE MARKET GROWTH 66
TABLE 14 GENOMICS MARKET FOR SEQUENCING, BY REGION,
2018-2025 (USD MILLION) 67
TABLE 15 GENOMICS MARKET FOR SEQUENCING, BY COUNTRY,
2018-2025 (USD MILLION) 67
TABLE 16 GENOMICS MARKET FOR SEQUENCING, BY TYPE,
2018-2025 (USD MILLION) 68
7.3 PCR 68
7.3.1 PCR ALLOWS RESEARCHERS TO PRODUCE MILLIONS OF COPIES OF A SPECIFIC DNA SEQUENCE WITHIN HOURS 68
TABLE 17 GENOMICS MARKET FOR PCR, BY REGION, 2018-2025 (USD MILLION) 69
TABLE 18 GENOMICS MARKET FOR PCR, BY COUNTRY, 2018-2025 (USD MILLION) 69
7.4 NUCLEIC ACID EXTRACTION AND PURIFICATION 70
7.4.1 ADVANCES IN NUCLEIC ACID EXTRACTION AND PURIFICATION TECHNOLOGIES ARE EXPECTED TO SUPPORT THE GROWTH OF THIS MARKET 70
TABLE 19 GENOMICS MARKET FOR NUCLEIC ACID EXTRACTION AND PURIFICATION,
BY REGION, 2018-2025 (USD MILLION) 70
TABLE 20 GENOMICS MARKET FOR NUCLEIC ACID EXTRACTION AND PURIFICATION,
BY COUNTRY, 2018-2025 (USD MILLION) 71
7.5 MICROARRAYS 71
7.5.1 HIGH ADOPTION OF NGS MAY LIMIT THE GROWTH OF MICROARRAY TECHNOLOGIES IN THIS MARKET TO A CERTAIN EXTENT 71
TABLE 21 GENOMICS MARKET FOR MICROARRAYS, BY REGION,
2018-2025 (USD MILLION) 72
TABLE 22 GENOMICS MARKET FOR MICROARRAYS, BY COUNTRY,
2018-2025 (USD MILLION) 72
7.6 OTHER TECHNOLOGIES 73
TABLE 23 GENOMICS MARKET FOR OTHER TECHNOLOGIES, BY REGION,
2018-2025 (USD MILLION) 73
TABLE 24 GENOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY,
2018-2025 (USD MILLION) 74

8 GENOMICS MARKET, BY APPLICATION 75
8.1 INTRODUCTION 76
TABLE 25 GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 76
8.2 DRUG DISCOVERY AND DEVELOPMENT 76
8.2.1 DRUG DISCOVERY AND DEVELOPMENT FORMS THE LARGEST APPLICATION SEGMENT OF THE GENOMICS MARKET 76
TABLE 26 GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2018-2025 (USD MILLION) 77
TABLE 27 GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION) 77
8.3 DIAGNOSTICS 78
8.3.1 GROWING APPLICATIONS OF GENOMICS IN THE DIAGNOSTICS FIELD TO PROPEL MARKET GROWTH 78
TABLE 28 GRANTS, BY CANCER TYPE (AS OF OCTOBER 2020) 78
TABLE 29 GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION,
2018-2025 (USD MILLION) 80
TABLE 30 GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY,
2018-2025 (USD MILLION) 81
TABLE 31 GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2018-2025 (USD MILLION) 81
8.4 AGRICULTURE AND ANIMAL RESEARCH 82
8.4.1 GENOMICS HELPS IN IMPROVING THE PRODUCTIVITY OF CROPS AND LIVESTOCK—A KEY FACTOR DRIVING MARKET GROWTH 82
TABLE 32 GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH APPLICATIONS, BY REGION, 2018-2025 (USD MILLION) 82
TABLE 33 GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION) 83
8.5 OTHER APPLICATIONS 83
TABLE 34 GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION,
2018-2025 (USD MILLION) 84
TABLE 35 GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2018-2025 (USD MILLION) 84

9 GENOMICS MARKET, BY END USER 85
9.1 INTRODUCTION 86
TABLE 36 GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION) 86
9.2 HOSPITALS & CLINICS 86
9.2.1 INCREASING DEMAND FOR PHARMACOGENOMICS TO DRIVE THE ACCEPTANCE OF NGS IN HOSPITALS 86
TABLE 37 GENOMICS MARKET FOR HOSPITALS & CLINICS, BY REGION,
2018-2025 (USD MILLION) 87
TABLE 38 GENOMICS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY,
2018-2025 (USD MILLION) 88
9.3 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 88
9.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE THE USAGE OF GENOMICS PRODUCTS AMONG ACADEMIC & GOVERNMENT INSTITUTES 88
TABLE 39 GENOMICS MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2018-2025 (USD MILLION) 89
TABLE 40 GENOMICS MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION) 89
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 90
9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE THE USE OF GENOMICS PRODUCTS & SERVICES AMONG PHARMA & BIOTECH COMPANIES 90
TABLE 41 GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION) 90
TABLE 42 GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION) 91
9.5 OTHER END USERS 91
TABLE 43 GENOMICS MARKET FOR OTHER END USERS, BY REGION,
2018-2025 (USD MILLION) 92
TABLE 44 GENOMICS MARKET FOR OTHER END USERS, BY COUNTRY,
2018-2025 (USD MILLION) 92

10 GENOMICS MARKET, BY REGION 93
10.1 INTRODUCTION 94
FIGURE 19 NORTH AMERICA WILL CONTINUE TO DOMINATE THE GENOMICS MARKET DURING THE FORECAST PERIOD 94
TABLE 45 GENOMICS MARKET, BY REGION, 2018-2025 (USD MILLION) 95
10.2 NORTH AMERICA 95
FIGURE 20 NORTH AMERICA: GENOMICS MARKET SNAPSHOT 96
TABLE 46 NORTH AMERICA: GENOMICS MARKET, BY COUNTRY,
2018-2025 (USD MILLION) 97
TABLE 47 NORTH AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE,
2018-2025 (USD MILLION) 97
TABLE 48 NORTH AMERICA: GENOMICS MARKET, BY TECHNOLOGY,
2018-2025 (USD MILLION) 97
TABLE 49 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION,
2018-2025 (USD MILLION) 98
TABLE 50 NORTH AMERICA: GENOMICS MARKET, BY END USER,
2018-2025 (USD MILLION) 98
10.2.1 US 98
10.2.1.1 US dominates the North American genomics market 98
TABLE 51 US: GENOMICS MARKET, BY PRODUCT & SERVICE,
2018-2025 (USD MILLION) 99
TABLE 52 US: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION) 99
TABLE 53 US: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 100
TABLE 54 US: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION) 100
10.2.2 CANADA 100
10.2.2.1 Increasing research in the field of genomics to drive market growth 100
TABLE 55 CANADA: GENOMICS MARKET, BY PRODUCT & SERVICE,
2018-2025 (USD MILLION) 101
TABLE 56 CANADA: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION) 101
TABLE 57 CANADA: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 101
TABLE 58 CANADA: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION) 102
10.3 EUROPE 102
TABLE 59 EUROPE: GENOMICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 102
TABLE 60 EUROPE: GENOMICS MARKET, BY PRODUCT & SERVICE,
2018-2025 (USD MILLION) 103
TABLE 61 EUROPE: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION) 103
TABLE 62 EUROPE: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 103
TABLE 63 EUROPE: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION) 104
10.3.1 UK 104
10.3.1.1 Availability of government funding and strategic collaborations with biotech firms to boost the market 104
TABLE 64 UK: GENOMICS MARKET, BY PRODUCT & SERVICE,
2018-2025 (USD MILLION) 105
TABLE 65 UK: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION) 105
TABLE 66 UK: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 105
TABLE 67 UK: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION) 106
10.3.2 GERMANY 106
10.3.2.1 Increasing awareness of NGS in the country to boost the market growth in Germany 106
TABLE 68 GERMANY: GENOMICS MARKET, BY PRODUCT & SERVICE,
2018-2025 (USD MILLION) 107
TABLE 69 GERMANY: GENOMICS MARKET, BY TECHNOLOGY,
2018-2025 (USD MILLION) 107
TABLE 70 GERMANY: GENOMICS MARKET, BY APPLICATION,
2018-2025 (USD MILLION) 107
TABLE 71 GERMANY: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION) 108
10.3.3 FRANCE 108
10.3.3.1 Increasing government investments in genomics to boost the growth of the French genomics market 108
TABLE 72 FRANCE: GENOMICS MARKET, BY PRODUCT & SERVICE,
2018-2025 (USD MILLION) 108
TABLE 73 FRANCE: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION) 109
TABLE 74 FRANCE: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 109
TABLE 75 FRANCE: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION) 109
10.3.4 ROE 110
TABLE 76 ROE: GENOMICS MARKET, BY PRODUCT & SERVICE,
2018-2025 (USD MILLION) 110
TABLE 77 ROE: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION) 111
TABLE 78 ROE: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 111
TABLE 79 ROE: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION) 111
10.4 ASIA PACIFIC 112
FIGURE 21 ASIA PACIFIC: GENOMICS MARKET SNAPSHOT 113
TABLE 80 ASIA PACIFIC: GENOMICS MARKET, BY COUNTRY,
2018-2025 (USD MILLION) 114
TABLE 81 ASIA PACIFIC: GENOMICS MARKET, BY PRODUCT & SERVICE,
2018-2025 (USD MILLION) 114
TABLE 82 ASIA PACIFIC: GENOMICS MARKET, BY TECHNOLOGY,
2018-2025 (USD MILLION) 114
TABLE 83 ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION,
2018-2025 (USD MILLION) 115
TABLE 84 ASIA PACIFIC: GENOMICS MARKET, BY END USER,
2018-2025 (USD MILLION) 115
10.4.1 CHINA 115
10.4.1.1 China is expected to command the largest share of the Asia Pacific market 115
TABLE 85 CHINA: GENOMICS MARKET, BY PRODUCT & SERVICE,
2018-2025 (USD MILLION) 116
TABLE 86 CHINA: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION) 116
TABLE 87 CHINA: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 117
TABLE 88 CHINA: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION) 117
10.4.2 JAPAN 117
10.4.2.1 Growing conferences and workshops on newer genomics technologies such as NGS to increase awareness and drive the market 117
TABLE 89 JAPAN: GENOMICS MARKET, BY PRODUCT & SERVICE,
2018-2025 (USD MILLION) 118
TABLE 90 JAPAN: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION) 118
TABLE 91 JAPAN: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 119
TABLE 92 JAPAN: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION) 119
10.4.3 INDIA 119
10.4.3.1 Emergence of local players & increasing adoption of genomics technologies is expected to aid the growth of the genomics market in India 119
TABLE 93 INDIA: GENOMICS MARKET, BY PRODUCT & SERVICE,
2018-2025 (USD MILLION) 120
TABLE 94 INDIA: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION) 120
TABLE 95 INDIA: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 121
TABLE 96 INDIA: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION) 121
10.4.4 REST OF ASIA PACIFIC 121
TABLE 97 ROAPAC: GENOMICS MARKET, BY PRODUCT & SERVICE,
2018-2025 (USD MILLION) 122
TABLE 98 ROAPAC: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION) 122
TABLE 99 ROAPAC: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 122
TABLE 100 ROAPAC: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION) 123
10.5 REST OF THE WORLD 123
TABLE 101 ROW: GENOMICS MARKET, BY REGION, 2018-2025 (USD MILLION) 123
TABLE 102 ROW: GENOMICS MARKET, BY PRODUCT & SERVICE,
2018-2025 (USD MILLION) 123
TABLE 103 ROW: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION) 124
TABLE 104 ROW: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 124
TABLE 105 ROW: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION) 124
10.5.1 LATIN AMERICA 125
10.5.1.1 Expansions of key players in Latin American regions to boost the market 125
TABLE 106 LATIN AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE,
2018-2025 (USD MILLION) 125
TABLE 107 LATIN AMERICA: GENOMICS MARKET, BY TECHNOLOGY,
2018-2025 (USD MILLION) 125
TABLE 108 LATIN AMERICA: GENOMICS MARKET, BY APPLICATION,
2018-2025 (USD MILLION) 126
TABLE 109 LATIN AMERICA: GENOMICS MARKET, BY END USER,
2018-2025 (USD MILLION) 126
10.5.2 MIDDLE EAST & AFRICA 126
10.5.2.1 Increasing adoption of genetic testing in the Middle East and rising HIV & cancer incidence in Africa are driving market growth 126
TABLE 110 MIDDLE EAST & AFRICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 127
TABLE 111 MIDDLE EAST & AFRICA: GENOMICS MARKET, BY TECHNOLOGY,
2018-2025 (USD MILLION) 128
TABLE 112 MIDDLE EAST & AFRICA: GENOMICS MARKET, BY APPLICATION,
2018-2025 (USD MILLION) 128
TABLE 113 MIDDLE EAST & AFRICA: GENOMICS MARKET, BY END USER,
2018-2025 (USD MILLION) 129

11 COMPETITIVE LANDSCAPE 130
11.1 INTRODUCTION 130
11.2 MARKET SHARE ANALYSIS 130
FIGURE 22 GENOMICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019 130
11.3 MARKET EVALUATION FRAMEWORK 131
TABLE 114 MARKET EVALUATION FRAMEWORK: PRODUCT & SERVICE LAUNCHES —THE MAJOR STRATEGY ADOPTED BY PLAYERS 131
11.4 COMPETITIVE BENCHMARKING 131
11.4.1 ANALYSIS OF THE PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE GENOMICS MARKET 131
11.5 COMPETITIVE SCENARIO 132
11.5.1 KEY PRODUCT LAUNCHES 132
11.5.2 KEY COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS 132
11.5.3 KEY EXPANSIONS 133
11.5.4 KEY ACQUISITIONS 134
11.6 COMPANY EVALUATION MATRIX 134
11.6.1 GLOBAL GENOMICS MARKET: COMPANY EVALUATION MATRIX (OVERALL MARKET) (2019) 134
11.6.1.1 Stars 134
11.6.1.2 Emerging leaders 135
11.6.1.3 Pervasive players 135
11.6.1.4 Participants 135
FIGURE 23 GLOBAL GENOMICS MARKET: COMPANY EVALUATION MATRIX, 2019 136
11.6.2 COMPETITIVE LEADERSHIP MAPPING (START-UPS) (2019) 137
11.6.2.1 Progressive companies 137
11.6.2.2 Starting blocks 137
11.6.2.3 Dynamic companies 137
11.6.2.4 Responsive companies 137
FIGURE 24 COMPETITIVE LEADERSHIP MAPPING: GENOMICS MARKET 138

12 COMPANY PROFILES 139
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 MAJOR PLAYERS 139
12.1.1 ILLUMINA, INC. 139
FIGURE 25 ILLUMINA, INC.: COMPANY SNAPSHOT (2019) 139
12.1.2 THERMO FISHER SCIENTIFIC, INC. 143
FIGURE 26 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019) 143
12.1.3 QIAGEN N.V. 147
FIGURE 27 QIAGEN N.V.: COMPANY SNAPSHOT (2019) 147
12.1.4 AGILENT TECHNOLOGIES 151
FIGURE 28 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2020) 151
12.1.5 F. HOFFMANN-LA ROCHE, LTD. 156
FIGURE 29 F. HOFFMANN-LA ROCHE, LTD.: COMPANY SNAPSHOT (2019) 156
12.1.6 BIO-RAD LABORATORIES, INC. 160
FIGURE 30 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019) 160
12.1.7 EUROFINS SCIENTIFIC 163
FIGURE 31 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019) 163
12.1.8 OXFORD NANOPORE TECHNOLOGIES 165
12.1.9 BGI 167
12.1.10 DANAHER CORPORATION 170
FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 170
12.1.11 EPPENDORF AG 173
FIGURE 33 EPPENDORF AG: COMPANY SNAPSHOT (2019) 173
12.1.12 MERCK KGAA 175
FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2019) 175
12.1.13 NEW ENGLAND BIOLABS 177
12.1.14 PROMEGA CORPORATION 179
12.1.15 CREATIVE BIOGENE 180
12.1.16 START-UP/SME PLAYERS 181
12.1.16.1 Novogene Co., Ltd. 181
12.1.16.2 Helix OpCo, LLC 182
12.1.16.3 23andMe, Inc. 182
12.1.16.4 Personal Genome Diagnostics Inc. (PGDx) 183
12.1.16.5 Personalis, Inc. 184
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

13 APPENDIX 185
13.1 DISCUSSION GUIDE 185
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 190
13.3 AVAILABLE CUSTOMIZATIONS 192
13.4 RELATED REPORTS 192
13.5 AUTHOR DETAILS 194